Supratik Chattopadhyay
Overview
Explore the profile of Supratik Chattopadhyay including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
108
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Amirthanayagam A, Wood M, Teece L, Ismail A, Leighton R, Jacob A, et al.
Cancers (Basel)
. 2023 Sep;
15(17).
PMID: 37686610
A longitudinal, descriptive, prospective, and prolective study of individuals with endometrial or cervical cancer/pre-cancer diagnoses and high BMI (over 35 kg/m) undergoing RH was conducted. Of the 53 participants recruited,...
2.
Barakat A, Ismail A, Chattopadhyay S
J Obstet Gynaecol Res
. 2022 Sep;
48(12):3233-3241.
PMID: 36151704
Aim: Surgery for advanced ovarian cancer (AOC) has evolved over the past decade to ingeminate the need to offer maximum effort surgery (MES). The aim of this study is to...
3.
Barakat A, Ismail A, Chattopadhyay S, Davies Q
Cancer Diagn Progn
. 2022 Sep;
2(5):564-568.
PMID: 36060021
Background/aim: It is well established that around one-third of patients with atypical endometrial hyperplasia (AEH) go on to develop endometrial cancer (EC). Patients And Methods: This retrospective cohort study included...
4.
Barakat A, Ismail A, Davies Q, Chattopadhyay S
In Vivo
. 2022 Jun;
36(4):1834-1840.
PMID: 35738607
Background/aim: Some studies have shown that ovarian cancer patients admitted after referral to the emergency department had a worse prognosis than those referred through non-emergency pathways. We believe that our...
5.
Barakat A, Ismail A, Chattopadhyay S
In Vivo
. 2022 Apr;
36(3):1544-1550.
PMID: 35478136
Background/aim: The Royal College of Obstetricians and Gynaecologists (RCOG) introduced a new curriculum in 2019. Furthermore, the National Health Service was hit by the COVID 19 pandemic in 2020. Our...
6.
Collins A, Spooner S, Horne J, Chainrai M, Runau F, Bourne T, et al.
Anticancer Res
. 2021 Jun;
41(6):3059-3065.
PMID: 34083298
Background: Peri-operative variables associated with prolonged Intensive Care Unit (ICU) admission following cytoreductive surgery for ovarian cancer were investigated. Patients And Methods: A retrospective review was carried out of patients...
7.
Chattopadhyay S, Cross P, Nayar A, Galaal K, Naik R
Int J Gynecol Cancer
. 2013 Mar;
23(4):690-7.
PMID: 23518862
Objective: Depth of myometrial invasion is considered as the strongest predictor of distant failure and death from disease in stage I endometrial cancer. The aim of this study was to...
8.
Al Rawahi T, Lopes A, Bristow R, Bryant A, Elattar A, Chattopadhyay S, et al.
Cochrane Database Syst Rev
. 2013 Mar;
(2):CD008765.
PMID: 23450588
Background: The standard management of primary ovarian cancer is optimal cytoreductive surgery followed by platinum-based chemotherapy. Most women with primary ovarian cancer achieve remission on this combination therapy. For women...
9.
Chattopadhyay S, Mittal S, Christian S, Terblanche A, Patel A, Biliatis I, et al.
Int J Gynecol Cancer
. 2012 Nov;
23(1):199-207.
PMID: 23154265
Objective: To determine the effect of fluid optimization using esophageal Doppler monitoring (EDM) when compared to standard fluid management in women who undergo major gynecological cancer surgery and whether its...
10.
Biliatis I, Kucukmetin A, Patel A, Ratnavelu N, Cross P, Chattopadhyay S, et al.
Gynecol Oncol
. 2012 Apr;
126(1):73-7.
PMID: 22465521
Objective: Current surgical treatment of FIGO stage 1B1 cervical cancer is radical surgery. However, several reports have shown that for small tumours a more conservative approach can be as effective...